The overexpression of YAP1 can promote proliferation, migration, and invasion of SKOV3 and A2780 cell lines, and inhibit their apoptosis (Lin et al., 2020), while inhibiting YAP, a co-activator of the Hippo signaling pathway, can inhibit the drug resistance of ovarian cancer (Muñoz-Galván et al., 2020). Here, YAP1 is linked to ovarian cancer.